Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-08-050023

President and CEO bought 164,000 shares

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2008-08-22 Purchase : show line 1 in the form +164,000 164,000 D
Open-market purchases · 164,000 sh

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2008-08-22 Purchase : show line 2 in the form Common Stock Warrant +164,000 164,000 D
Loading xslF345X03/rrd216680.xml…